1. a) All patients identified at a reporting facility with a non-duplicative XDRO are reportable to the Registry within seven calendar days after the test result is finalized.

2. b) A reporting facility may report XDRO infections by one of the following methods:

   1. 1) Option #1. Electronic Reporting: Health care facilities that have the capacity to submit laboratory data electronically may use this option.
   2. 2) Option #2. Manual Entry into a Website: Facilities that do not have the capacity to submit laboratory data electronically shall submit the data through a Department-approved website.
3. c) All reporting facilities are responsible for complete case finding, which means identifying all non-duplicative XDRO isolates.

(Source: Added at 37 Ill. Reg. 12063, effective July 15, 2013)